Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Development and IND-enabling studies of a novel Cas9 geno... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
0
Authors
Varun Katta
32 more
Varun Katta
•
Kiera O'Keefe
30 more
•
Shengdar Tsai
Published
May 2, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Internal Medicine
Genetics And Genomics
Show all topics
DOI
10.1101/2024.04.30.591737
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Internal Medicine
Genetics And Genomics
Show all topics
DOI
10.1101/2024.04.30.591737
License
cc-no